Figure 1.
Consort diagram of the population included in the study.
Table 1.
Baseline characteristics of study population, stratified by presence of in-hospital and follow-up cardiac events.
Figure 2.
Relation of fluorescent AGEs and sRAGE with the type of ACS.
Box plots for fluorescent AGE (A) and sRAGE (B) plasma levels for non ST-segment elevation acute coronary syndrome patients (NST-ACS) and ST-segment elevation myocardial infarction (STEMI).
Table 2.
Baseline characteristics based on quartiles of fluorescent AGE.
Table 3.
Baseline characteristics based on quartiles of sRAGE.
Table 4.
Clinical outcomes based on quartiles of sRAGE and fluorescent AGE.
Figure 3.
Relation of sRAGE levels and risk categories of different ACS scores.
Columns represent mean values (indicated in numbers) for sRAGE plasma levels in each category of the indicated scores.
Figure 4.
Survival Kaplan Meier curves according fluorescent AGE quartiles.
Inset represent curves magnifications about survival free of events.
Figure 5.
Curves of sensitivity and specificity for fluorescent AGEs and sRAGE to predict events.
A) representation of sRAGE curves to predict in-hospital events and B) fluorescent AGE curves to predict follow-up events.
Table 5.
Multiple regression analysis for in-hospital and follow-up events.